Results 41 to 50 of about 114,510 (249)

Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2019
Objective: Intravesical hyaluronic acid (HA) therapy is one of acceptable methods to treat bladder pain and storage symptoms (i.e., urgency, frequency and nocturia) of interstitial cystitis/bladder pain syndrome (IC/BPS).
Man-Jung Hung   +5 more
doaj   +1 more source

Low-Energy Shock Wave Plus Intravesical Instillation of Botulinum Toxin A for Interstitial Cystitis/Bladder Pain Syndrome: Pathophysiology and Preliminary Result of a Novel Minimally Invasive Treatment

open access: yesBiomedicines, 2022
Low-energy shock wave (LESW) therapy is known to facilitate tissue regeneration with analgesic and anti-inflammatory effects. LESW treatment has been demonstrated to be effective in treating chronic prostatitis and pelvic pain syndrome as well as ...
Yuan-Hong Jiang   +3 more
doaj   +1 more source

A case of refractory intractable bladder pain syndrome treated with superior hypogastric nerve chemical neurolysis

open access: yesIndian Journal of Pain, 2023
Bladder pain syndrome (BPS) is a severely debilitating condition. BPS is a symptom complex affecting the urinary bladder, which is characterized by pelvic pain, urinary urgency, frequency, and nocturia.
Rutvi Manoj Mody   +2 more
doaj   +1 more source

Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome

open access: yesBMC Urology, 2020
Background To evaluate the efficacy of submucosal injection of triamcinolone acetonide for the treatment of type II/III interstitial cystitis/bladder pain syndrome.
Tao Jiang   +8 more
doaj   +1 more source

Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome

open access: yesCellular Physiology and Biochemistry, 2016
Background/Aims: To assess the efficacy of intravesical hyaluronic acid (HA) and HA/chondroitin sulfate (CS) instillation in patients with interstitial cystitis/painful bladder syndrome by systematic review and meta-analysis.
Jung-Soo Pyo, Won Jin Cho
doaj   +1 more source

Can Botulinum Toxin A Play a Role in Treatment of Chronic Pelvic Pain Syndrome in Female Patients?—Clinical and Animal Evidence

open access: yesToxins, 2020
Chronic pelvic pain (CPP) is defined as chronic pain and inflammation in the pelvic organs for more than six months. There are wide ranges of clinical presentations, including pelvic pain, painful intercourse, irritable bowel syndrome, and pain during ...
Chin-Li Chen, En Meng
doaj   +1 more source

BOTULINUM TOXIN A FOR THE MANAGEMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

open access: yesВестник урологии, 2017
Interstitial Cystitis/Bladder Pain Syndrome is a chronic and debilitating condition that negatively impacts quality of life. Several causes have been postulated in the pathogenesis of this condition; however, the etiology remains unknown.
V. L. Medvedev, S. N. Lepetunov
doaj   +1 more source

Spinal column shortening versus revision detethering for recurrent adult tethered cord syndrome: a preliminary comparison of perioperative and clinical outcomes. [PDF]

open access: yes, 2020
OBJECTIVE:Recurrent tethered cord syndrome (TCS), believed to result from tension on the distal portion of the spinal cord, causes a constellation of neurological symptoms. Detethering surgery has been the traditional treatment for TCS. However, in cases
Chang, Chih-Chang   +7 more
core   +1 more source

Bladder Pain Syndrome (Interstitial Cystitis) Consensus 2019: The Report of the Turkish Continence Society Bladder Pain Syndrome/ Interstitial Cystitis Working Group

open access: yesJournal of Urological Surgery, 2020
Bladder pain syndrome is an important chronic pain syndrome which seriously reduces the patients’ quality of life. It is a diagnosis of exclusion. It is defined as a clinical diagnosis composed of chronic (>6 months) pain/pressure/discomfort that is ...
Taner Koçak   +5 more
doaj   +1 more source

Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study [PDF]

open access: yes, 2006
Objective: We evaluated the efficacy and tolerability of botulinum A toxin (BTX-A) intravesical injections in patients affected by painful bladder syndrome with increased urinary frequency, refractory to conventional treatment modalities. Methods: Twelve
Bini, V   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy